NCT01146860View on ClinicalTrials.gov

Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis

PHASE3CompletedINTERVENTIONAL
Enrollment

386

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Acute Rhinosinusitis
Interventions
DRUG

BNO 1016

sugar coated tablets with dry extract (80 mg) of 5 herbal drugs; dosage: 480 mg per day (2 tablets t.i.d.) duration: 15 days

DRUG

Placebo

sugar coated tablets with identical appearance to active treatment; frequency: 2 tablets t.i.d. duration 15 days

Trial Locations (1)

82178

Dr. Rainer Jund, Specialist in Otorhinolaryngology, Puchheim

Sponsors

Lead Sponsor

Bionorica SE
All Listed Sponsors
lead

Bionorica SE

INDUSTRY